article · European Journal of Pharmacology

From liver to kidney: Telmisartan attenuates NLRP3 inflammasome-driven systemic inflammation and the iNOS/Hsp70 axis partially via the Mas receptor in a hepatic ischemia-reperfusion model

Hasan Shehata
Hanan S. El‐Abhar
Dalaal M. Abdallah
Ayman A. Soubh

20252 citationsFuture University in Egypt

In plain language

No abstract is available for this record, so no summary has been generated.

Research topics

Inflammasome and immune disorders
Liver Disease Diagnosis and Treatment
Liver Disease and Transplantation

Sustainable Development Goals

Good Health and Well-being

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

View on publisher site Record on OpenAlex

DOI: 10.1016/j.ejphar.2025.178098

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.

New to MARATTO™? Create a free account.